Navigation Links
Pemphigus in Medical News

Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments

...rofessionals and representatives from other organizations including The Neuropathy Association, Foundation for Peripheral Neuropathy and International pemphigus and Pemphigoid Foundation to learn about neuropathy and to promote awareness of the disease. Patients and patient advocates in attendance signed a pe...

New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin

... Project, Clinical Immunology Society, Foundation for Peripheral Neuropathy, GBS/CIDP Foundation International, Infusion Nurses Society, International pemphigus and Pemphigoid Foundation, Jeffrey Modell Foundation, The Myositis Association, National Patient Advocate Foundation, The Neuropathy Association, Neur...

Peptimmune Announces the Second Close of Series D Private Financing

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, and Silicon Valley Bank Capital. ...

Rockefeller University's Center for Clinical and Translational Science funds pilot studies

...smitted drug resistance. Mouquet Hugo, postdoctoral fellow in Michel Nussenzweigs Laboratory of Molecular Immunology, to elucidate the etiology of pemphigus vulgaris, a life-threatening autoimmune disease affecting skin and mucosa, by comparing repertoires of autoreactive and polyreactive B cells in patien...

Lymphoma drug used to treat skin disorders

...he off-label uses of rituximab in dermatology and found that it successfully treated patients with various kinds of blistering skin disease, including pemphigus vulgaris, dermatomyositis, and paraneoplastic pemphigus. Newer, safer treatments are being studied for serious dermatologic disorders, and rituxima...
Pemphigus in Medical Technology

Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, Silicon Valley Bank Capital, and ...

Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, Silicon Valley Bank Capital, and ...

Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt BioVentures, Boston Medical Investors, and Silicon Valley Capital Par...

Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, Silicon Valley Bank Capital, and ...

Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Prism Venture Partners, Vanguard Ventures, Hunt Ventures, Boston Medical I...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

...h Roche for the development of CellCept in autoimmune indications; and our two phase III clinical programs underway with CellCept: lupus nephritis and pemphigus vulgaris. With respect to the forward-looking statements contained in this news release, we have made numerous assumptions regarding, among other th...
Pemphigus in Medical Products

Paraneoplastic Pemphigus Antibody Screen

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

IgA Pemphigus Antibodies

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Anti-Skin Antibody (ASA) Test Kit

Description:... Anti-Skin Antibody (ASA) Test Kit: pemphigus and Bullous Pemphigoid...
Company:Inverness Medical Innovations
Pemphigus in Medical Dictionary

Scalded skin syndrome

... Staphylococcal scalded skin syndrome , SSSS, also known as pemphigus neonatorum or Ritter's disease, is a dermatological condition caused by Staphylococcus aureus. Staphylococcal scalded skin syndrome (SSS...
Pemphigus in Biological News

Scientists stop autoimmune disease without shutting off immune system

...a rare, life-threatening autoimmune disease called pemphigus vulgaris lack that protection because their immune... immune system offered a lifeline to patients with pemphigus vulgaris (PV) and other autoimmune disorders, but ...nzyme called p38 is part of the mechanism by which pemphigus vulgaris autoantibodies cause damage. Autoantibodi...
Pemphigus in Biological Technology

Peptimmune Presentations at Upcoming Events

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, Silicon Valley Bank Capital, and ...

Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, Silicon Valley Bank Capital, and ...

Peptimmune Announces First Close of Series D Private Financing

...n clinical development with second-generation therapeutics that are expected to result in safer and more effective products for multiple sclerosis and pemphigus vulgaris. Current investors include New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, and Silicon Valley Bank Capital. ...
Other Tags
(Date:7/7/2015)... ... ... Safe Catch is setting revolutionary purity limits for canned tuna as the only ... Markets, Sprouts Farmers Market and Wegmans are some of the first grocers to stock ... mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch tuna for health ...
(Date:7/7/2015)... ... 07, 2015 , ... The Immune Deficiency Foundation (IDF) launched ... using its IDF ePHR, an electronic personal health record powered by Get Real ... track their health information, including symptoms, diagnoses, medications, infusions and other critical health ...
(Date:7/7/2015)... Manistee, Michigan (PRWEB) , ... July 07, 2015 , ... ... a fundraising golf outing at the Manistee Golf and Country Club. Best Drug Rehabilitation ... went to a good cause, helping underprivileged children. Kiwanis International, the parent of the ...
(Date:7/7/2015)... ... July 07, 2015 , ... On June ... the site of the National Baptist Convention 110th Annual Session of the National ... promoting the collaboration of churches and their congregations, medical professionals and health-related organizations, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Georgia Partnership for ... communities throughout Georgia, announces the launch of the first ambulance telemedicine program in ... County, GA. The new program will not only provide more immediate patient care, ...
Breaking Medicine News(10 mins):Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/23/2015)... PALM BEACH GARDENS, Fla. , June ... of multi-factor identity management and authentication solutions, today ... Altus strong, multi-factor authentication solution.  The ... ease of use of the DigitalPersona Altus ... and biometric reader compatibility. In ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market announces that its Wocket® smart wallet will ... the Mark", scheduled to air on WABC Radio (am770) in ... . The broadcast air- time for the ... EST. NXT-ID, Inc.,s CEO Gino Pereira will be ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
Other Contents